Preferred Name |
ombitasvir |
|
Synonyms |
ABT-267 |
|
ID |
http://purl.bioontology.org/ontology/MESH/C586094 |
|
altLabel |
ABT-267 ABT267 N,N'-(((2S,5S)-1-(4-(1,1-dimethylethyl)phenyl)-2,5-pyrrolidinediyl)bis(4,1-phenyleneiminocarbonyl-(2S)-2,1-pyrrolidinediyl((1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl)))bis-C,C'-dimethyl ester carbamic acid |
|
cui |
C3852670 C3713322 |
|
HM |
D014633 D011392 D000813 |
|
II |
D000998 |
|
Inverse of RB |
2302768XJ8 0 |
|
Mapped to |
http://purl.bioontology.org/ontology/MESH/D014633 |
|
MDA |
20140202 |
|
MeSH Frequency |
281 |
|
MMR |
20210722 |
|
notation |
C586094 |
|
prefLabel |
ombitasvir |
|
SC |
1 |
|
Scope Statement |
inhibits HCV NS5A protein, component of Viekirax |
|
SRC |
N Engl J Med. 2014 Jan 16;370(3):222-32. |
|
TERMUI |
T854475 T859644 T001109080 T001109079 |
|
TH |
FDA SRS (2017) NLM (2021) USAN (19XX) INN (19XX) NLM (2014) |
|
tui |
T109 T121 |
Create mapping